ImmuneSpec is a next-generation immunopeptidomics platform that delivers unmatched precision in identifying peptides presented by MHC molecules. Powered by advanced mass spectrometry, ImmuneSpec provides deep, unbiased insight into immune presentation—enabling the development of safer, more effective biotherapeutics. The platform supports early detection of immunogenic regions in biologics, reducing immune risk and guiding safer drug design. ImmuneSpec also accelerates target discovery by revealing rare neoepitopes and validates constructs by confirming that designed epitopes are effectively presented. With rapid turnaround, high-throughput capability, and rigorous quality control, ImmuneSpec empowers researchers to advance transformative therapies—from personalized medicine to next-generation vaccines and immunotherapies.
| Website | http://www.immunespec.com |
| Employees | 15 (8 on RocketReach) |
| Founded | 2023 |
| Phone | +32 797707610 |
| Industry | Biotechnology Research |
| Keywords | Immuno-Oncology, Mass Spectrometry, Peptide Sequencing, Precision Medicine, Immunology Research, Protein Analysis, Proteomics, Biomarker Discovery, Biotechnology, Therapeutic Peptides, Drug Discovery, Clinical Trials, Immunotherapy, Life Sciences, Cancer Research, Vaccine Development |
| Competitors | Thermo Fisher Scientific, R&D Systems, Bio-Rad Laboratories, PEPROTECH EC LTD, MilliporeSigma, abcam, GenScript, Santa Cruz Biotechnology (SCBT), Miltenyi Biotec, Cell Signaling Technology (CST) +41 more (view full list) |
Looking for a particular ImmuneSpec employee's phone or email?
Elise Pepermans is the CEO and co-founder of ImmuneSpec.
8 people are employed at ImmuneSpec.